Terkko Navigator / Salven, P.

Decoding cancer cell death-driven immune cell recruitment: An in vivo method for site-of-vaccination analyses

Lymphatic Vascular Structures: A New Aspect in Proliferative Diabetic Retinopathy

Pathogen response-like recruitment and activation of neutrophils by sterile immunogenic dying cells drives neutrophil-mediated residual cell killing

A Case of Abnormal Lymphatic-Like Differentiation and Endothelial Progenitor Cell Activation in Neovascularization Associated with Hemi-Retinal Vein Occlusion

Indications of lymphatic endothelial differentiation and endothelial progenitor cell activation in the pathology of proliferative diabetic retinopathy

Stem cells in cancer

TIM-family molecules in embryonic hematopoiesis: fetal liver TIM-4(lo) cells have myeloid potential

Concise review: endothelial stem and progenitor cells and their habitats

Generation of functional blood vessels from a single c-kit+ adult vascular endothelial stem cell

Dual action of TGF-β induces vascular growth in vivo through recruitment of angiogenic VEGF-producing hematopoietic effector cells

Somatic progenitor cell vulnerability to mitochondrial DNA mutagenesis underlies progeroid phenotypes in Polg mutator mice

High serum angiogenin at diagnosis predicts for failure on long-term treatment response and for poor overall survival in non-Hodgkin lymphoma

Stem cells in tumor angiogenesis

The EGFR inhibitor gefitinib suppresses recruitment of pericytes and bone marrow-derived perivascular cells into tumor vessels

Bone marrow-derived circulating endothelial precursors do not contribute to vascular endothelium and are not needed for tumor growth

VEGFR-1 and -2 regulate inflammation, myocardial angiogenesis, and arteriosclerosis in chronically rejecting cardiac allografts

Critical function of Bmx/Etk in ischemia-mediated arteriogenesis and angiogenesis

Contribution of bone marrow-derived pericyte precursor cells to corneal vasculogenesis

Stem cells as spare parts for humans, tomorrow's promise or nonsense

PDGF-D induces macrophage recruitment, increased interstitial pressure, and blood vessel maturation during angiogenesis

Adult bone marrow-derived cells recruited during angiogenesis comprise precursors for periendothelial vascular mural cells

Preexisting lymphatic endothelium but not endothelial progenitor cells are essential for tumor lymphangiogenesis and lymphatic metastasis

CD14 and TNfa promoter polymorphisms in patients with acute arthritis. Special reference to development of chronic spondyloarthropathy

High pretreatment serum concentration of basic fibroblast growth factor is a predictor of poor prognosis in small cell lung cancer

VEGFR-3 and CD133 identify a population of CD34+ lymphatic/vascular endothelial precursor cells

Interleukin-1alpha promotes angiogenesis in vivo via VEGFR-2 pathway by inducing inflammatory cell VEGF synthesis and secretion

Angiogenic and lymphangiogenic molecules in hematological malignancies

Angiogenesis in lymphoproliferative disorders

Endotoxins induce and interferon alpha suppresses vascular endothelial growth factor (VEGF) production in human peripheral blood mononuclear cells

Interferon alpha-2a therapy in 18 hemangioblastomas

Simultaneous elevation in the serum concentrations of the angiogenic growth factors VEGF and bFGF is an independent predictor of poor prognosis in non-Hodgkin lymphoma: a single-institution study of 200 patients

Vascular permeability factor/vascular endothelial growth factor in nasal polyps

Major surgery increases serum levels of vascular endothelial growth factor only temporarily

A high pretreatment serum basic fibroblast growth factor concentration is an independent predictor of poor prognosis in non-Hodgkin's lymphoma

Kaposi's sarcoma-associated herpesvirus-encoded v-cyclin triggers apoptosis in cells with high levels of cyclin-dependent kinase 6

VEGFR-3 and its ligand VEGF-C are associated with angiogenesis in breast cancer

Serum VEGF levels in women with a benign breast tumor or breast cancer

Leukocytes and platelets of patients with cancer contain high levels of vascular endothelial growth factor

Blood platelets and serum VEGF in cancer patients

Peripheral blood platelets express VEGF-C and VEGF which are released during platelet activation

Vascular endothelial growth factors VEGF-B and VEGF-C are expressed in human tumors

High pre-treatment serum level of vascular endothelial growth factor (VEGF) is associated with poor outcome in small-cell lung cancer

Lymphatic endothelium and Kaposi's sarcoma spindle cells detected by antibodies against the vascular endothelial growth factor receptor-3

Vascular endothelial growth factor in squamous cell head and neck carcinoma: expression and prognostic significance

A high pretreatment serum vascular endothelial growth factor concentration is associated with poor outcome in non-Hodgkin's lymphoma

Serum vascular endothelial growth factor is often elevated in disseminated cancer

Enhanced expression of vascular endothelial growth factor in metastatic melanoma

Endothelial Tie growth factor receptor provides antigenic marker for assessment of breast cancer angiogenesis

Genes protecting from cancer

Primary structure of the brain alpha-spectrin